Altogether, these findings demonstrate that combining either anti-PD-1 or anti-PD-L1, with Ad5-CMV-mTNFα/mIL-2 provides potent stimulation and infiltration of cytotoxic T cells to the tumor microenvironment ultimately contributing to improved overall survival. The gene discussed is CD274; the disease is neoplasm.